Delivra Health Valuation
| DHBUF Stock | USD 0.01 0 10.24% |
Delivra Health seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Delivra Health Brands from reviewing the firm fundamentals such as Shares Outstanding of 252.62 M, current valuation of 4.15 M, and Profit Margin of (0.77) % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Delivra Health's price fluctuation is out of control at this time. Calculation of the real value of Delivra Health Brands is based on 3 months time horizon. Increasing Delivra Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Delivra otc stock is determined by what a typical buyer is willing to pay for full or partial control of Delivra Health Brands. Since Delivra Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Delivra OTC Stock. However, Delivra Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.014 | Real 0.0126 | Hype 0.01 | Naive 0.0145 |
The real value of Delivra OTC Stock, also known as its intrinsic value, is the underlying worth of Delivra Health Brands OTC Stock, which is reflected in its stock price. It is based on Delivra Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Delivra Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Delivra Health Brands helps investors to forecast how Delivra otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Delivra Health more accurately as focusing exclusively on Delivra Health's fundamentals will not take into account other important factors: Delivra Health Total Value Analysis
Delivra Health Brands is currently anticipated to have takeover price of 4.15 M with market capitalization of 3.71 M, debt of 1.67 M, and cash on hands of 1.67 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Delivra Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.15 M | 3.71 M | 1.67 M | 1.67 M |
Delivra Health Investor Information
About 22.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. Delivra Health Brands had not issued any dividends in recent years. The entity had 1:1 split on the 28th of April 2017. Based on the key indicators obtained from Delivra Health's historical financial statements, Delivra Health Brands is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Delivra Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Delivra Health has an asset utilization ratio of 70.25 percent. This implies that the OTC Stock is making $0.7 for each dollar of assets. An increasing asset utilization means that Delivra Health Brands is more efficient with each dollar of assets it utilizes for everyday operations.Delivra Health Ownership Allocation
Delivra Health holds a total of 252.62 Million outstanding shares. Delivra Health Brands retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Delivra Health Profitability Analysis
The company reported the revenue of 8.14 M. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 2.6 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Delivra Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Delivra Health and how it compares across the competition.
About Delivra Health Valuation
The otc valuation mechanism determines Delivra Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Delivra Health. We calculate exposure to Delivra Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Delivra Health's related companies.Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada. Delivra Health is traded on OTC Exchange in the United States.
8 Steps to conduct Delivra Health's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Delivra Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Delivra Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Delivra Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Delivra Health's revenue streams: Identify Delivra Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Delivra Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Delivra Health's growth potential: Evaluate Delivra Health's management, business model, and growth potential.
- Determine Delivra Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Delivra Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Delivra Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as Delivra Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 252.6 M | |
| Retained Earnings | -169.9 M |
Complementary Tools for Delivra OTC Stock analysis
When running Delivra Health's price analysis, check to measure Delivra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delivra Health is operating at the current time. Most of Delivra Health's value examination focuses on studying past and present price action to predict the probability of Delivra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delivra Health's price. Additionally, you may evaluate how the addition of Delivra Health to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |